Browse EyeWorld Weekly ophthalmology news on EyeWorld.org. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
➤ Topline results from Phase 3 pivotal trial evaluating mydriasis drug ➤ First person dosed in Phase 3 trial for first-in-class dry eye candidate ➤ Phase 2 study of a novel glaucoma drop targeting non-traditional outflow ➤ Digital vision screening platform with machine learning ➤ Alcon to acquire dry eye drop and inflammation/pain drop ➤ New issue online ➤ ASCRS news and events
➤ Phase 4 results evaluating intravitreal implant ➤ Interim results for X-linked retinitis pigmentosa treatment ➤ New non-contact glaucoma laser treatment receives CE mark ➤ Companies collaborate for regenerative dry eye therapy ➤ Complimentary MIGS video series ➤ ASCRS news and events
➤ 36- and 48-month efficacy demonstrated with canaloplasty ➤ Phase 1/2 trial for gene therapy for X-linked retinitis pigmentosa ➤ Topline results from Phase 2a trial for possible DME therapy ➤ Preclinical data shows potential for gene therapy to address Leber congenital amaurosis ➤ ASCRS news and events
➤ FDA approves image and data management/analysis platform ➤ Results from pivotal Phase 3 trial for new Demodex treatment ➤ Trial demonstrates safety, efficacy of mydriasis-reversal drug in pediatric patients ➤ Phase 3 pivotal trial for novel dry eye disease, MGD drug candidate ➤ Phase 3 results for investigational geographic atrophy therapy ➤ New coalition supports sustainability in ophthalmology ➤ ASCRS news and events
➤ Topline results from Phase 3 trials of presbyopia-mitigating drop ➤ Study: Long-term visual outcomes of at-home telemonitoring ➤ AAO IRIS Registry Report ➤ Innovations in capsulotomy technology ➤ Complimentary access to video journal ➤ ASCRS news and events
➤ FDA approves new phaco system ➤ Next-generation canaloplasty device launch ➤ New Nd:YAG laser launch ➤ Researchers explore non-surgical option to address vision loss ➤ Non-invasive method to examine conjunctival goblet cells in vivo ➤ ASCRS news and events
➤ Phase 3 clinical trials complete for ‘superpotent’ corticosteroid ➤ New rapid, quantitative MMP-9 tear test ➤ First pediatric patient dosed with experimental gene-editing therapy for Leber congenital amaurosis ➤ Study: Comparison of NCX 470 to latanoprost for glaucoma ➤ Collaborations for inherited retinal diseases ➤ ASCRS news and events
➤ Topline data from Phase 3 trial of presbyopia-correcting drop ➤ FDA gives 510(K) approval to updated neuromodulation therapy for increased tear production ➤ Enrollment complete for Phase 3 trial of reproxalap ➤ DME trial to focus on underrepresented patient populations ➤ BLA submitted to FDA for wet AMD therapy ➤ Companies collaborate to further develop gene therapy for retinal disease ➤ ASCRS news and events
➤ FDA approves new ICL ➤ Home tonometer receives 510(k) clearance ➤ First patient treated in what will be the largest standalone MIGS clinical trial ➤ Topline results from second Phase 3 trial of mydriasis-reversing drug ➤ ASCRS news and events
➤ Launch of Phase 3 clinical trial for presbyopia drop candidate ➤ Topline results for investigational dry eye therapy ➤ Positive findings for photobiomodulation dry AMD treatment ➤ Enrollment completed for investigational oral diabetic retinopathy therapy ➤ Longer-term data from Phase 3 studies evaluating geographic atrophy therapy released ➤ Orphan drug designation granted to investigational retinitis pigmentosa treatment ➤ ASCRS news and events
Get the latest ophthalmology news delivered to your inbox every Friday.